百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

已收盘 09-23 16:08:14

218.200

+0.600

+0.28%

最高221.400	最低217.000	成交量264.65万
今开221.000	昨收217.600	日振幅2.02%
总市值3,365亿	流通市值3,114亿	总股本15.42亿
成交额5.79亿	换手率0.19%	流通股本14.27亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":218.2,"timestamp":1790150894007,"preClose":217.6,"halted":0,"volume":2646540,"delay":0,"changeRate":0.0027573529411764447,"floatShares":1427000000,"shares":1542000000,"eps":1.4902311426935535,"marketStatus":"已收盘","change":0.6,"latestTime":"09-23 16:08:14","open":221,"high":221.4,"low":217,"amount":578725075,"amplitude":0.020221,"askPrice":218.2,"askSize":48500,"bidPrice":218,"bidSize":17300,"shortable":3,"etf":0,"ttmEps":3.3722362094794387,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790213400000},"marketStatusCode":5,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":217.6,"openAndCloseTimeList":[[1790127000000,1790136000000],[1790139600000,1790150400000]],"volumeRatio":0.806848,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":266.49,"timestamp":1790146800000,"preClose":268.66,"halted":0,"volume":2305800,"delay":0,"premium":"-29.99"},"impliedVol":0.2086,"impliedVolPercentile":0.006},"requestUrl":"/m/hq/s/06160/wiki","defaultTab":"wiki","newsList":[{"id":"2669617615","title":"快讯：恒指低开0.09% 科指涨0.01% 科网股分化 存储概念股高开","url":"https://stock-news.laohu8.com/highlight/detail?id=2669617615","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669617615?lang=zh_cn&edition=full","pubTime":"2026-09-23 09:20","pubTimestamp":1790126400,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端美股周二表现个别发展，油价由高位回落，利好大市气氛，道指高开后升幅一度扩大，其后在金融及科技股拖累下，市况由升转跌，三大指数收市升跌不一。美元高位徘徊，美国十年期债息维持于4.95厘水平，金价低位靠稳，油价继续回落。今日港股三大指数涨跌不一，恒指开盘跌0.09%，报25064.84点，恒科指涨0.01%，国企指数跌0.07%。盘面上，科网股涨跌不一，百度涨超1%，阿里跌近1%；存储概念股高开，南方两倍做多三星电子涨超7%；黄金股回暖，紫金黄金国际涨超2%；创新药概念股活跃，百济神州涨超1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-23/doc-inisunsp1425823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02837","BK1500","83115","LU0588546209.SGD","02833","03033","03417","09067","03419","09115","LU2328871848.SGD","03037","513600","09088","LU1770034418.SGD","BK1161","03088","KURE","LU1251922891.USD","LU1303224171.USD","82800","06160","LU1969619763.USD","ONC","07226","07200","02800","BK1588","03423","BK1583","HHImain","LU0228659784.USD","LU0307460666.USD","07300","HSTECH","HSI","LU0828237510.HKD","03115","MCHmain","LU1719994722.HKD","03067","07552","688235","03032","07500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120025372","title":"异动解读｜百济神州盘中上涨3.01%，生物医药板块集体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1120025372","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120025372?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:51","pubTimestamp":1789959110,"startTime":"0","endTime":"0","summary":"9月21日，百济神州盘中上涨3.01%，报219.0港元/股，成交额3.59亿港元。消息面上，港股生物医药板块盘初普升，康方生物涨超6%、科伦博泰生物涨超5%、药明生物涨超4%，板块情绪整体回暖。基本面方面，公司上半年营收32.19亿美元，同比增长32.3%；净利润4.64亿美元，同比增长385.8%。核心产品百悦泽全球销售额达23.42亿美元，同比增长34.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州受资金追捧，创新药板块集体走强","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136031","title":"生物医药板块盘初普升 复宏汉霖（02696）涨7.96% 机构指中国创新药进入全球价值兑现阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136031","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669136031?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:49","pubTimestamp":1789955355,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普升，截至发稿，复宏汉霖 涨7.96%，诺诚健华涨7.34%，荣昌生物涨6.69%，康诺亚-B涨6.52%，康方生物涨6.46%，君实生物涨6.41%，金斯瑞生物科技涨5.80%，科伦博泰生物涨5.63%，药明生物涨4.47%，药明康德涨2.90%，泰格医药涨2.69%，百济神州涨2.07%，药明合联涨1.75%。中信证券表示，中国创新药进入全球价值兑现阶段，头部国际化创新药企业有望迎来产品全球价值兑现期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/OTZhY2RjY2M0NGRhYmE3MDgxYTI5ZDA4OTNlODY4MjM3MDk5ODc3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/OTZhY2RjY2M0NGRhYmE3MDgxYTI5ZDA4OTNlODY4MjM3MDk5ODc3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992049","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","09926","LU0634319403.HKD","01548","03347","LU2242644610.SGD","LU0326950275.SGD","02696","02268","LU0463099449.HKD","LU2045819591.USD","LU0456827905.SGD","01877","09969","XBI","LU0244354667.USD","02162","LU0979878070.USD","LU0029874905.USD","BK4588","06990","161726","BK1610","399441","06160","LU0540923850.HKD","09995","LU1188198961.HKD","LU1880383366.USD","HK0000165453.HKD","LU0348784397.USD","LU0561508036.HKD","BK1588","LU1961090484.USD","LU0348766576.USD","LU2476274720.SGD","LU0052750758.USD","KURE","LU0516422952.EUR","LU0348767384.USD","LU1303224171.USD","LU2488822045.USD","LU0128522744.USD","02359","LU0320764599.SGD","LU0320764243.SGD","BK1515","02269","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919819","title":"CXO板块上扬 昭衍新药（06127）涨5.64%、金斯瑞生物科技（01548）涨4.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919819","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668919819?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:46","pubTimestamp":1789695974,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块上扬，昭衍新药 涨5.64%，金斯瑞生物科技涨4.78%，维亚生物涨2.15%，泰格医药涨1.93%，药明生物涨1.80%，凯莱英涨1.79%，药明康德涨1.01%，百济神州涨0.95%。中信建投近日研报指，CXO是创新药产业链专业化分工的重要载体，也是连接药物研发与商业化生产的关键基础设施。随着内外需改善逐步传导至订单与业绩，CXO有望进入新一轮增长阶段。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991930","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","LU0348735423.USD","02269","BK1588","LU0469268626.HKD","LU1880383366.USD","LU0588546209.SGD","BK0216","LU0634319403.HKD","02359","603127","LU0359202008.SGD","LU1251922891.USD","LU0456846285.SGD","WX","01548","LU0320764599.SGD","LU3063872942.SGD","LU0348825331.USD","LU0052750758.USD","CXO","BK1161","BK1521","LU0228659784.USD","LU1242518931.SGD","LU1719994722.HKD","LU0128522744.USD","LU2039709279.SGD","LU0516423174.USD","06821","LU0561508036.HKD","LU0039217434.USD","LU0029874061.USD","LU1242518857.USD","SG9999002562.SGD","LU0029874905.USD","06127","LU0828237510.HKD","BK1610","LU0051755006.USD","LU1688375341.USD","IE00B0JY6N72.USD","LU0348827113.USD","LU0181495838.USD","03347","LU0856984785.SGD","LU0320764243.SGD","01873","06160","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667989077","title":"【千亿药企龙头深度拆解】百济神州：全球化创新药标杆，强壁垒下的结构性矛盾","url":"https://stock-news.laohu8.com/highlight/detail?id=2667989077","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667989077?lang=zh_cn&edition=full","pubTime":"2026-09-16 16:22","pubTimestamp":1789546920,"startTime":"0","endTime":"0","summary":"在港股上市的千亿市值药企阵营里，百济神州是最特殊的一员。需要留意的是，百济神州与诺华的海外授权协议已于2023年正式终止，百济神州收回该产品全部全球开发、生产及商业化权益，实现海外自主商业化运营。百泽安已成为公司实体瘤板块的全球自研核心品种，有效补充血液瘤单一赛道的收入结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI2MDAzMTQ4OA==&mid=2650514206&idx=1&sn=4292ea5ae8182ba933de653526e8bdb4&chksm=f37a88f7cd05119f50f0ce0fe4212017c82f46c59ff4f2dfff69e4c09b2b61480edf204662d8&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["06160","LU0828237510.HKD","BK1588","LU2328871848.SGD","LU1251922891.USD","LU1770034418.SGD","LU1719994722.HKD","BK1583","BK1161","06978","BK1574","BK1500","KURE","LU0588546209.SGD","LU1969619763.USD","LU0228659784.USD","LU0307460666.USD","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132805056","title":"异动解读｜百济神州盘中下跌3.2%，生物科技板块整体走弱叠加董事近期减持","url":"https://stock-news.laohu8.com/highlight/detail?id=1132805056","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132805056?lang=zh_cn&edition=full","pubTime":"2026-09-16 13:19","pubTimestamp":1789535993,"startTime":"0","endTime":"0","summary":"9月16日，百济神州盘中下跌3.2%，报205.6港元，成交额3.24亿港元。消息面上，生物科技板块整体承压，同板块康方生物跌4.67%、维立志博跌5.95%、荣昌生物跌2.52%，行业个股普遍走弱。此外，公司董事王晓东近日减持38,287股，套现约1,336.61万美元，短期情绪面有所扰动。基本面方面，公司上半年营收32.19亿美元，同比增长32.3%，净利润4.64亿美元，同比增长385.8%，盈利能力持续兑现，多家机构维持\"买入\"评级。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"百济神州盘中走弱，生物科技板块承压","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654360","title":"百济神州员工购股计划完成购买812,149股 涉及4,590名员工","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654360","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667654360?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:09","pubTimestamp":1789376940,"startTime":"0","endTime":"0","summary":"9月14日，百济神州(06160.HK)宣布，截至2026年8月31日认购期结束，4,590名合资格雇员根据2018员工购股计划合共购买62,473股美国存托股份，涉及股份数目为812,149股，占已发行股份总数约0.05 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260914/c679883948.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260914/c679883948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU1303224171.USD","06160","BK4139","BK4585","BK1583","BK1588","BK1500","LU0228659784.USD","BK0239","ONC","LU2328871848.SGD","LU1719994722.HKD","LU1969619763.USD","KURE","BK4526","LU1770034418.SGD","LU0828237510.HKD","LU1251922891.USD","BK4588","BK1161","LU0588546209.SGD","LU0307460666.USD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113246203","title":"百济神州（06160）披露2018员工购股计划最新进展：4,590名员工认购62,473份ADS","url":"https://stock-news.laohu8.com/highlight/detail?id=1113246203","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113246203?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:01","pubTimestamp":1789376496,"startTime":"0","endTime":"0","summary":"百济神州有限公司9月14日公告，截至2026年3月2日至2026年8月31日的认购期结束，公司共有4,590名合资格全职员工通过2018员工购股计划购买62,473份美国存托股份，对应812,149股普通股，占公司已发行股份总数约0.05%。参与员工在认购期内共计从薪金中扣除17,091,157.78美元用于购股。公告显示，本次购股后，2018员工购股计划下仍有4,822,408股普通股授权额度可供未来授出。百济神州表示，通过持续提供股权激励机会，可进一步加强员工与股东利益的一致性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651186","title":"百济神州(06160.HK)：合共6.25万股美国存托股份由4590名参与者根据2018员工购股计划购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651186","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667651186?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:58","pubTimestamp":1789376313,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0828237510.HKD","KURE","LU0588546209.SGD","LU0307460666.USD","LU1303224171.USD","BK1583","BK1500","LU1251922891.USD","LU1719994722.HKD","LU0228659784.USD","06160","BK1161","LU1969619763.USD","LU1770034418.SGD","LU2328871848.SGD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186702031","title":"异动解读｜百济神州盘中上涨3.01%，国际资管巨头大举增持叠加生物科技板块走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1186702031","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186702031?lang=zh_cn&edition=full","pubTime":"2026-09-14 14:31","pubTimestamp":1789367506,"startTime":"0","endTime":"0","summary":"9月14日，百济神州盘中上涨3.01%，报212.4港元，成交额4.7亿港元。消息面上，国际资管巨头The Capital Group近日以均价约348.48美元/股增持百济神州307万股，涉资约10.70亿美元，增持后持股比例由6.97%升至7.17%。同时，巴克莱维持公司\"增持\"评级，目标价415美元。基本面方面，公司上半年营收32.19亿美元，同比增长32.3%；净利润4.64亿美元，同比增长385.8%；经调整净利润8.20亿美元，同比增逾一倍，盈利能力持续兑现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州股价上涨，国际资管巨头大举增持","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667049502","title":"每周股票复盘：百济神州（688235）推员工购股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2667049502","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667049502?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:31","pubTimestamp":1789234268,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，百济神州报收于247.3元，较上周的271.0元下跌8.75%。本周，百济神州9月7日盘中最高价报269.64元。来自公司公告汇总：百济神州发布2026中期报告，董事会成员发生变更。公司公告汇总港股公告：员工购股计划百济神州有限公司宣布，经股东于2026年6月11日批准的2018员工购股计划新一轮认购期自2026年9月1日至2027年2月26日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","KURE","BK0239","BK1161","LU1251922891.USD","LU0228659784.USD","LU1770034418.SGD","BK1583","LU2328871848.SGD","BK1588","BK1500","688235","LU1303224171.USD","LU1969619763.USD","LU0307460666.USD","LU1719994722.HKD","LU0828237510.HKD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521629","title":"百济神州：董事王晓东减持38287股，套现约1336.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521629","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666521629?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:31","pubTimestamp":1789126260,"startTime":"0","endTime":"0","summary":"南财智讯9月11日电，百济神州（BeOneMedicinesLtd.，纳斯达克：ONC）董事王晓东提交Form4持股变动声明。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113872228648.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113872228648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4526","BK1161","LU2328871848.SGD","02197","BK4139","LU1719994722.HKD","KURE","LU1969619763.USD","BK1500","06160","LU0828237510.HKD","LU1303224171.USD","LU0588546209.SGD","LU0307460666.USD","LU0228659784.USD","BK4588","ONC","688235","LU1770034418.SGD","BK1583","LU1251922891.USD","BK4585","BK0239","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191613108","title":"百济神州：The Capital Group Companies, Inc.增持美股","url":"https://stock-news.laohu8.com/highlight/detail?id=1191613108","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191613108?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:42","pubTimestamp":1789119742,"startTime":"0","endTime":"0","summary":"The Capital Group Companies, Inc.于2026年9月9日以每股均价348.4826美元买入百济神州股份307.04万股，涉资约10.70亿美元。The Capital Group Companies, Inc.此次增持前持有百济神州好仓1.08亿股，占比6.97%；增持后持股量为1.11亿股，好仓比例升至7.17%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561640","title":"百济神州（688235）披露员工购股计划新一轮认购期启动，9月10日股价下跌1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561640","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666561640?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:27","pubTimestamp":1789032453,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，百济神州报收于253.7元，较前一交易日下跌1.21%，最新总市值为3912.78亿元。该股当日开盘256.8元，最高258.34元，最低252.2元，成交额达4.44亿元，换手率为1.52%。近日，百济神州有限公司披露，经股东于2026年6月11日批准的2018员工购股计划新一轮认购期自2026年9月1日至2027年2月26日。申请期为2026年8月17日至8月31日，参与人数为5,316人。购股价格为认购期首尾两日纳斯达克收市价较低者的85%。该计划无业绩目标及退扣机制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000031135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","BK1500","LU1719994722.HKD","BK0239","KURE","LU0828237510.HKD","LU0307460666.USD","LU1770034418.SGD","LU1251922891.USD","688235","BK1583","LU2328871848.SGD","LU0588546209.SGD","LU1303224171.USD","BK1161","06160","BK1588","LU0228659784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120600611","title":"百济神州2026年中期财报营收32.19亿美元，经调整净利润8.20亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120600611","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120600611?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:37","pubTimestamp":1789029421,"startTime":"0","endTime":"0","summary":"百济神州公布截至2026年6月30日的中期财报：营收从上年同期的24.33亿美元同比增长32.3%至32.19亿美元。报告期内，经调整净利润约为8.20亿美元，较上年同期的3.89亿美元增长111%。财报显示，公司毛利为28.77亿美元，同比上升36.8%，主要来自产品销售额的快速提升。经调整经营利润约9.17亿美元，较上年同期的4.14亿美元增长逾一倍。此外，安加维收入同比提升28.1%至1.94亿美元，倍利妥收入同比增长42.6%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州2026年中期财报营收32.19亿美元，经调整净利润8.20亿美元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666128556","title":"【券商聚焦】中信证券：中国创新药进入全球价值兑现阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2666128556","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666128556?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:59","pubTimestamp":1789001960,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，2026年以来，中国创新药国内市场快速放量，从中报来看头部创新药企业在新产品驱动下，创新药收入快速增长，biopharma陆续进入盈利拐点；出海创新药开始进入三期/注册研究兑现阶段；近期多个国际学术大会将至，众多创新药管线进入密集的数据催化期。该机构认为中国创新药进入全球价值兑现阶段，建议关注：①头部国际化创新药企业有望迎来产品全球价值兑现期；②头部创新药企业产品放量进入新的成长阶段；③具有全球潜力的管线资产国际化有望加速兑现。综上，我们维持创新药行业“强于大市”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991210","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1580142542.USD","LU2148510915.USD","01801","LU0979878070.USD","LU1969619763.USD","02142","LU1794554557.SGD","LU1961090484.USD","06160","01093","LU1226287792.SGD","BK1141","06030","09995","IE00B543WZ88.USD","KCE","LU0572944931.SGD","01877","LU0181495838.USD","LU0348825331.USD","LU1820825898.SGD","LU2580892862.HKD","KURE","LU1064130708.USD","BK0028","02616","06185","LU0516422952.EUR","09926","LU1880383366.USD","LU0405327494.USD","BK1161","IE0008369823.USD","LU0463099449.HKD","09688","LU0348783233.USD","LU1226287875.USD","600030","LU1720050803.USD","LU0561508036.HKD","SG9999004220.SGD","LU0417516738.SGD","LU1813983027.USD","LU1997245177.USD","02269","01177","LU0819121731.USD","LU1255011170.USD","LU2039709279.SGD","LU1655091616.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107965927","title":"百济神州启动2026年下半年员工购股计划 5,316名员工已登记参与","url":"https://stock-news.laohu8.com/highlight/detail?id=1107965927","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107965927?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:56","pubTimestamp":1788944181,"startTime":"0","endTime":"0","summary":"百济神州9月9日公告，根据香港联交所上市规则第17.06A、17.06B及17.06C条，公司将于2026年9月01日至2027年02月26日启动新一轮“第六份经修订及经重列2018员工购股计划”认购期。该计划已获公司股东于2026年06月11日批准。截至申请期结束，已有5,316名合资格员工登记参与。公司表示，持续通过员工购股计划授予公司股权，可鼓励员工留任并使其利益与股东利益保持一致。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323620","title":"美股中概股盘前涨跌互现，百度跌7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665323620?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:01","pubTimestamp":1788854485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1880383440.USD","BK4575","ALBmain","LU0651946864.USD","IE0008368742.USD","EVS.SI","BK4558","LU0918141887.USD","BK4585","LU0328353924.USD","BK4085","LU0651947912.USD","09999","BK4607","LU1823568750.SGD","BK4535","BK4502","IE00BFMHRM44.USD","HK0000165453.HKD","LU0661504455.SGD","LU2226246903.HKD","LU1515016050.SGD","LU0463099449.HKD","BK4526","09866","BABO","09618","LU1282648689.USD","HK0000320223.HKD","KBAB","LU1003077747.HKD","LU0359201612.USD","BABU","BIDG","BK4563","BK4566","BK4077","LU1043141396.HKD","LU1960683339.HKD","IE00BYV24P56.USD","BABC","BK4099","LU0426412945.USD","BK4510","BK4614","LU0072462343.USD","HK0000320264.USD","KBDU","LU1048596156.SGD","09888","LU0588546209.SGD","BK4555","KJD","LU0052750758.USD","LU0426417589.USD","LU0320764599.SGD","IE00BF5LJ272.USD","LU0545562505.USD","BK4548","BK4504","IE00B0JY6N72.USD","LU0244354667.USD","LU0545039389.USD","BABA","LU1880383366.USD","LU1688375341.USD","BIDU","BK4577","LU1043141123.HKD","JD","NTES","688235","BK4220","BBYY","LU0640798160.USD","LU0918141705.HKD","BK4538","LU1051768304.USD","LU1242518931.SGD","LU1769817096.USD","BK4588","LU0052756011.USD","LU0047713382.USD","LU0501845795.SGD","BILI","NIOG","LU0072913022.USD","LU1267930227.SGD","LU0880133367.SGD","BK4139","LU0949170772.SGD","IE00BVYPNQ40.USD","HK0000306701.USD","BK4554","BK4543","LU0173614495.USD","LU0251143458.SGD","LU0359202008.SGD","LU1152091168.USD","HERO","LU0456842615.SGD","BK4505","LU1235294995.USD","LU0553294199.USD","LU0310800965.SGD","NERD","BK4552","IE00BGV7N243.SGD","BK4503","LU0287142896.SGD","LU0128525689.USD","CLIX","LU1008478684.HKD","NIO","LU0106959298.USD","BK4531","LU1807302812.USD","ONC","ESPO","DRGN","IE00BGHQDM52.EUR","BK4122","BK4524","DRAG","LU0979878070.USD","LU1115378108.SGD","BK4514","ONLN","LU2148611432.USD","IE00BVYPNP33.GBP","NIO.SI","BK4565","LU1152091754.HKD","LU1046422090.SGD","BK4527","BK4574","LU0067412154.USD","LU1046421795.USD","LU1048588211.SGD","LI","09988","02015","LU1121112475.USD","BK4532","LU0326950275.SGD","LU0348816934.USD","BK4513","BABW","ODDS","BK4534","SG9999002463.SGD","LU1242518857.USD","LU1993786604.SGD","06160","LU0797268264.HKD","LU1023057109.AUD","BABX","HK0000306685.HKD","BK4579","LU0307460666.USD","LU1051769294.HKD","LU1228905540.USD","LU0821914370.USD","BK4602","BK4533","09626","LU0994945656.USD","LU1188198961.HKD","BK4551","LU1105468828.SGD","LU1228905037.USD","IE00BMCWC346.EUR","LU1769817179.HKD","BK4509","LU0708995583.HKD","BK4612","LU0738911758.USD","LU0348814723.USD","BK4501","BK4587","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155287714","title":"异动解读｜百济神州盘中下跌3.08%，美国Medicaid药价协议余波或仍在消化","url":"https://stock-news.laohu8.com/highlight/detail?id=1155287714","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155287714?lang=zh_cn&edition=full","pubTime":"2026-09-07 10:11","pubTimestamp":1788747098,"startTime":"0","endTime":"0","summary":"9月7日，百济神州盘中下跌3.08%，报214.0港元，成交额2.51亿港元。消息面上，公司此前宣布与美国政府就替雷利珠单抗达成Medicaid定价协议，以约定价格向符合条件患者供应，预计覆盖约8%的美国已获批适应症患者群体。尽管多家券商指出泽布替尼等核心血液瘤产品价格体系未受影响，短期财务冲击有限并维持买入评级，但市场对美国药价政策的担忧情绪或仍在消化中。同业方面，生物科技板块整体偏弱，康方生物跌1.78%，基石药业跌1.37%，信达生物持平。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"百济神州股价下挫，美药价协议冲击待消化","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665395840","title":"里昂：中国生物科技基本面仍稳固 首选百济神州(06160.HK)、信达生物(01801.HK)及维立志博(09887.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665395840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665395840?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:52","pubTimestamp":1788745948,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2488822045.USD","BK1161","BK1583","LU2328871848.SGD","BK1588","LU2097828557.USD","LU0244354667.USD","LU0455707207.USD","LU1251922891.USD","LU1188198961.HKD","LU0307460666.USD","LU0463099449.HKD","HK0000500386.USD","LU2097828474.EUR","LU1303224171.USD","03069","KURE","LU2242644610.SGD","LU0828237510.HKD","LU1969619763.USD","LU2097828631.EUR","HK0000165453.HKD","HK0000252152.HKD","LU0588546209.SGD","LU1719994722.HKD","01801","09887","LU0326950275.SGD","LU0228659784.USD","HK0000252160.HKD","LU2097828714.EUR","BK1500","LU2097828805.USD","LU0502904849.HKD","BK1589","06160","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.0245},{"period":"1month","weight":-0.0456},{"period":"3month","weight":0.3172},{"period":"6month","weight":0.326},{"period":"1year","weight":0.0772},{"period":"ytd","weight":0.2136}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":-0.0354},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.0093},{"period":"1year","weight":-0.0477},{"period":"ytd","weight":-0.0212}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.034277},{"month":5,"riseRate":0.375,"avgChangeRate":-0.043816},{"month":6,"riseRate":0.375,"avgChangeRate":0.001624},{"month":7,"riseRate":0.875,"avgChangeRate":0.102282},{"month":8,"riseRate":0.875,"avgChangeRate":0.065066},{"month":9,"riseRate":0.555556,"avgChangeRate":0.023501},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEONE MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}